ABSTRACT
A chylothorax and a cholesterol pleural effusion represent the two forms of lipid
effusions encountered. Traditionally, a lipid pleural effusion is characterized by
the presence of milky fluid. Although these two effusions often share a similar pleural
fluid appearance due to the high lipid concentration, they have major differences
in the pathogenesis, clinical presentation, diagnosis, predisposing conditions, and
management of these effusions. A chylothorax is defined by the presence of chyle in
the pleural space resulting from obstruction or disruption of the thoracic duct or
one of its major tributaries. A triglyceride concentration > 110 mg/dL is virtually
diagnostic, but the presence of chylomicrons confirms the diagnosis. However, a chylothorax
defined by these criteria represents a heterogeneous group of clinical entities. The
presence of chylomicrons or triglyceride levels > 110 mg/dL in a pleural effusion
should be considered evidence of chyle leakage of indeterminate clinical significance.
Many cases of a chylous effusion may be associated with other causes of pleural fluid
formation. In the case of an acute or chronic chylothorax due to recent or remote
thoracic duct injury, this assessment is essential, as surgical ligation of the thoracic
duct is often entertained. In other cases, especially lymphoma or chylous ascites,
treatment of the underlying condition is indicated regardless, and the assessment
of the response to treatment is a reasonable initial approach. In contrast, a cholesterol
effusion is typically the result of long-standing pleurisy with elevated cholesterol
levels in the pleural space; however, this paradigm has been challenged. Lung entrapment
with thickened parietal and visceral pleural membranes is the typical radiographic
findings of a cholesterol effusion. Most cases of cholesterol pleural effusions are
attributed to tuberculous or rheumatoid pleurisy. Decortication is the mainstay of
treatment for a cholesterol effusion in symptomatic patients with restrictive lung
function.
KEYWORDS
Chylothorax - cholesterol effusion - pseudochylothorax - review
REFERENCES
1
Agrawal V, Sahn S A.
Lipid pleural effusions.
Am J Med Sci.
2008;
335
16-20
2
Doerr C H, Miller D L, Ryu J H.
Chylothorax.
Semin Respir Crit Care Med.
2001;
22
617-626
3
Staats B A, Ellefson R D, Budahn L L, Dines D E, Prakash U B, Offord K.
The lipoprotein profile of chylous and nonchylous pleural effusions.
Mayo Clin Proc.
1980;
55
700-704
4
Merrigan B A, Winter D C, O'Sullivan G C.
Chylothorax.
Br J Surg.
1997;
84
15-20
5
Nair S K, Petko M, Hayward M P.
Aetiology and management of chylothorax in adults.
Eur J Cardiothorac Surg.
2007;
32
362-369
6
Zilversmit D B.
The composition and structure of lymph chylomicrons in dog, rat, and man.
J Clin Invest.
1965;
44
1610-1622
7
Van Pernis P A.
Variations of the thoracic duct.
Surgery.
1949;
26
806-809
8
McGrath E E, Blades Z, Anderson P B.
Chylothorax: aetiology, diagnosis and therapeutic options.
Respir Med.
2010;
104
1-8
9
Valentine V G, Raffin T A.
The management of chylothorax.
Chest.
1992;
102
586-591
10
Doerr C H, Allen M S, Nichols III F C, Ryu J H.
Etiology of chylothorax in 203 patients.
Mayo Clin Proc.
2005;
80
867-870
11
Fairfax A J, McNabb W R, Spiro S G.
Chylothorax: a review of 18 cases.
Thorax.
1986;
41
880-885
12
Bolger C, Walsh T N, Tanner W A, Keeling P, Hennessy T P.
Chylothorax after oesophagectomy.
Br J Surg.
1991;
78
587-588
13
Dougenis D, Walker W S, Cameron E W, Walbaum P R.
Management of chylothorax complicating extensive esophageal resection.
Surg Gynecol Obstet.
1992;
174
501-506
14
Orringer M B, Bluett M, Deeb G M.
Aggressive treatment of chylothorax complicating transhiatal esophagectomy without
thoracotomy.
Surgery.
1988;
104
720-726
15
Suemitsu R, Ondo K, Fukuyama S, Ueda H.
Late-period-onset chylothorax after a pulmonary resection for lung cancer: a case
report.
Ann Thorac Cardiovasc Surg.
2007;
13
345-348
16
Halldorsson A.
Chylothorax after coronary artery bypass grafting.
Int Surg.
2009;
94
119-129
17
Zaidenstein R, Cohen N, Dishi V, Alon I, Golik A, Modai D.
Chylothorax following median sternotomy.
Clin Cardiol.
1996;
19
910-912
18
Ng R S, Kerbavaz R J, Hilsinger Jr R L.
Bilateral chylothorax from radical neck dissection.
Otolaryngol Head Neck Surg.
1985;
93
814-817
19
Han C, Guo L, Wang K J, Zhao J Q.
Bilateral chylothorax following neck dissection for thyroid cancer.
Int J Oral Maxillofac Surg.
2009;
38
1119-1122
20
Patel N, Lewandowski R J, Bove M, Nemcek Jr A A, Salem R.
Thoracic duct embolization: a new treatment for massive leak after neck dissection.
Laryngoscope.
2008;
118
680-683
21
Busquets J M, Rullan P J, Trinidad-Pinedo J.
Bilateral chylothorax after neck dissection.
Otolaryngol Head Neck Surg.
2004;
130
492-495
22
Kurekci E, Kaye R, Koehler M.
Chylothorax and chylopericardium: a complication of a central venous catheter.
J Pediatr.
1998;
132
1064-1066
23
Silen M L, Weber T R.
Management of thoracic duct injury associated with fracture-dislocation of the spine
following blunt trauma.
J Trauma.
1995;
39
1185-1187
24
Worthington M G, de Groot M, Gunning A J, von Oppell U O.
Isolated thoracic duct injury after penetrating chest trauma.
Ann Thorac Surg.
1995;
60
272-274
25
Cammarata S K, Brush Jr R E, Hyzy R C.
Chylothorax after childbirth.
Chest.
1991;
99
1539-1540
26
Agrawal V, Doelken P, Sahn S A.
Seat belt-induced chylothorax: a cause of idiopathic chylothorax?.
Chest.
2007;
132
690-692
27
Reilly K M, Tsou E.
Bilateral chylothorax: a case report following episodes of stretching.
JAMA.
1975;
233
536-537
28
Parker J M, Torrington K G, Phillips Y Y.
Sarcoidosis complicated by chylothorax.
South Med J.
1994;
87
860-862
29
Lengyel R J, Shanley D J.
Recurrent chylothorax associated with sarcoidosis.
Hawaii Med J.
1995;
54
817-818
30
Aberg H, Bah M, Waters A W.
Sarcoidosis: complicated by chylothorax.
Minn Med.
1966;
49
1065-1070
31
Rabie H, Lomp A, Goussard P, Nel E, Cotton M.
Paradoxical tuberculosis associated immune reconstitution inflammatory syndrome presenting
with chylous ascites and chylothorax in a HIV-1 infected child.
J Trop Pediatr.
2010;
56
355-358
32
Goh K L, Tan H W, Loh T G, Yap S.
Chylothorax due to filariasis—a case report.
Singapore Med J.
1986;
27
173-176
33
Almoosa K F, McCormack F X, Sahn S A.
Pleural disease in lymphangioleiomyomatosis.
Clin Chest Med.
2006;
27
355-368
34
Ryu J H, Doerr C H, Fisher S D, Olson E J, Sahn S A.
Chylothorax in lymphangioleiomyomatosis.
Chest.
2003;
123
623-627
35
King P A, Ghosh A, Tang M H, Lam S K.
Recurrent congenital chylothorax.
Prenat Diagn.
1991;
11
809-811
36
Hillerdal G.
Yellow nail syndrome: treatment with octreotide.
Clin Respir J.
2007;
1
120-121
37
Maldonado F, Ryu J H.
Yellow nail syndrome.
Curr Opin Pulm Med.
2009;
15
371-375
38
Lee S, Finn L, Sze R W, Perkins J A, Sie K C.
Gorham Stout syndrome (disappearing bone disease): two additional case reports and
a review of the literature.
Arch Otolaryngol Head Neck Surg.
2003;
129
1340-1343
39
Goldblatt M, Huggins J T, Doelken P, Gurung P, Sahn S A.
Dasatinib-induced pleural effusions: a lymphatic network disorder?.
Am J Med Sci.
2009;
338
414-417
40
Agrawal V, Doelken P, Sahn S A.
Pleural fluid analysis in chylous pleural effusion.
Chest.
2008;
133
1436-1441
41
Maldonado F, Hawkins F J, Daniels C E, Doerr C H, Decker P A, Ryu J H.
Pleural fluid characteristics of chylothorax.
Mayo Clin Proc.
2009;
84
129-133
42
Al-Zubairy S A, Al-Jazairi A S.
Octreotide as a therapeutic option for management of chylothorax.
Ann Pharmacother.
2003;
37
679-682
43
Rimensberger P C, Müller-Schenker B, Kalangos A, Beghetti M.
Treatment of a persistent postoperative chylothorax with somatostatin.
Ann Thorac Surg.
1998;
66
253-254
44
Mares D C, Mathur P N.
Medical thoracoscopic talc pleurodesis for chylothorax due to lymphoma: a case series.
Chest.
1998;
114
731-735
45
Rizzardi G, Loy M, Marulli G, Rea F.
Persistent chylothorax in lymphangioleiomyomatosis treated by intrapleural instillation
of povidone.
Eur J Cardiothorac Surg.
2008;
34
214-215
46
Jianjun Q, Song Z, Yin L, Jia Z, Donglei L.
Treatment of chylothorax with elemene.
Thorac Cardiovasc Surg.
2008;
56
103-105
47
Cope C.
Percutaneous transabdominal embolization of thoracic duct lacerations in animals.
J Vasc Interv Radiol.
1996;
7
725-731
48
Cope C, Salem R, Kaiser L R.
Management of chylothorax by percutaneous catheterization and embolization of the
thoracic duct: prospective trial.
J Vasc Interv Radiol.
1999;
10
1248-1254
49
Cope C.
Management of chylothorax via percutaneous embolization.
Curr Opin Pulm Med.
2004;
10
311-314
50
Bybel B, Neumann D R, Kim B Y, Amin K, Rice T.
Lymphoscintigraphy using (99m)Tc filtered sulfur colloid in chylothorax: a case report.
J Nucl Med Technol.
2001;
29
30-31
51
Cerfolio R J, Allen M S, Deschamps C, Trastek V F, Pairolero P C.
Postoperative chylothorax.
J Thorac Cardiovasc Surg.
1996;
112
1361-1365, discussion 1365–1366
52
Cerfolio R J.
Chylothorax after esophagogastrectomy.
Thorac Surg Clin.
2006;
16
49-52
53
Dougenis D, Walker W S, Cameron E W, Walbaum P R.
Management of chylothorax complicating extensive esophageal resection.
Surg Gynecol Obstet.
1992;
174
501-506
54
Graham D D, McGahren E D, Tribble C G, Daniel T M, Rodgers B M.
Use of video-assisted thoracic surgery in the treatment of chylothorax.
Ann Thorac Surg.
1994;
57
1507-1511, discussion 1511–1512
55
Patterson G A, Todd T R, Delarue N C, Ilves R, Pearson F G, Cooper J D.
Supradiaphragmatic ligation of the thoracic duct in intractable chylous fistula.
Ann Thorac Surg.
1981;
32
44-49
56
Weems B F.
Cholesterolhydrothorax.
Am J Med Sci.
1918;
156
20
57
Wrightson J M, Stanton A E, Maskell N A, Davies R J, Lee Y C.
Pseudochylothorax without pleural thickening: time to reconsider pathogenesis?.
Chest.
2009;
136
1144-1147
58
Ferguson G C.
Cholesterol pleural effusion in rheumatoid lung disease.
Thorax.
1966;
21
577-582
59
Garcia-Zamalloa A, Ruiz-Irastorza G, Aguayo F J, Gurrutxaga N.
Pseudochylothorax: report of 2 cases and review of the literature.
Medicine (Baltimore).
1999;
78
200-207
60
Coe J E, Aikawa J K.
Cholesterol pleural effusion: report of 2 cases studied with isotopic techniques and
review of the world literature.
Arch Intern Med.
1961;
108
763-774
61
Hillerdal G.
Chyliform (cholesterol) pleural effusion.
Chest.
1985;
88
426-428
62
Hillerdal G.
Chylothorax and pseudochylothorax.
Eur Respir J.
1997;
10
1157-1162
63
Hamm H, Pfalzer B, Fabel H.
Lipoprotein analysis in a chyliform pleural effusion: implications for pathogenesis
and diagnosis.
Respiration.
1991;
58
294-300
64
Nogueras C, Monteagudo M, Vila M, Cabezuelo A, Mariscal D, Berlanga E.
Recent-onset tuberculous pleurisy presenting as pseudochylothorax.
Am J Med.
2002;
113
166-168
65
Sassoon C S, Light R W.
Chylothorax and pseudochylothorax.
Clin Chest Med.
1985;
6
163-171
66
Goldman A, Burford T H.
Cholesterol pleural effusion: a report of 3 cases with a cure by decortication.
Dis Chest.
1950;
18
586-594
J. Terrill HugginsM.D.
Department of Medicine, Division of Pulmonary, Critical Care, Allergy, and Sleep Medicine,
Medical University of South Carolina
96 Jonathan Lucas St., Ste 812-CSB, Charleston, SC 29425
Email: hugginjt@musc.edu